checkAd

     427  0 Kommentare uniQure Announces Proposed Public Offering - Seite 3

    uniQure Contacts

    For Investors:       For Media:
             
    Maria Cantor
    Direct : +339-970-7536
    Mobile: 617-680-9452
    m.cantor@uniQure.com 
      Eva M. Mulder
    Direct: +31 20 240 6103
    Mobile: +31 6 52 33 15 70
    e.mulder@uniQure.com
      Tom Malone
    Direct: 339-970-7758
    Mobile: 339-223-8541
    t.malone@uniqure.com



    Lesen Sie auch

    This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
    The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
    Source: uniQure N.V. via Globenewswire

    Seite 3 von 3



    GlobeNewswire
    0 Follower
    Autor folgen

    Verfasst von GlobeNewswire
    uniQure Announces Proposed Public Offering - Seite 3  uniQure N.V. (Nasdaq:QURE), a leading gene therapy company advancing transformative therapies for patients with severe unmet medical needs, such as hemophilia B, Huntington's disease and congestive heart failure, today announced that it has …